Together, they will find partners for the development of the ‘RSH Olfactory Delivery Device,’ a dual nostril intranasal platform used for precisely targeting specific regions of the nasal cavity.

Kindeva joins forces with Rocket Science Health to pioneer new Intranasal Delivery Platform 18 JUNE 2025: Kindeva, a global CDMO and drug delivery expert, and Rocket Science Health (RSH), a Canadian ...